Aortic Stenosis
Aortic stenosis occurs when the aortic valve narrows and stiffens causing failure of the valve. This is caused by calcium build up on the valve over time, and become more prevalent with advancing age
Our device(s) makes the TAVR procedure as accessible and adaptable as possible for alternative
access cases. We have prioritized ergonomics, simplicity, and efficacy for clinicians.
Aortic stenosis occurs when the aortic valve narrows and stiffens causing failure of the valve. This is caused by calcium build up on the valve over time, and become more prevalent with advancing age
Transcatheter Aortic Valve Replacement (TAVR) is the standard of care for aortic stenosis. TAVR is a minimally invasive procedure to replace diseased aortic valves with a prosthetic via catheter sheath. Normally, this is performed by entering the femoral artery to access the heart.
Edwards Lifesciences is the market leader for TAVR systems. The Edwards introducer eSheath is a specialized catheter delivery system utilized for TAVR. It aids in the safe access of arteries to deploy a replacement heart valve.
When the femoral artery is inaccessible, the clinician will use alternative access points such as transcarotid or trans-subclavian. Alternative access is much more difficult and strenuous for physicians because the current TAVR systems were not built for alternative access in mind.